06/23/2025 7:55 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2025 5:46 PM | Checkpoint Therapeutics, Inc. (Subject) Fortress Biotech, Inc. (Filed by) Fortress Biotech (Filed by)
| Form SCHEDULE 13D/A | |
06/03/2025 5:34 PM | Checkpoint Therapeutics, Inc. (Issuer) Fortress Biotech, Inc. (Reporting) Fortress Biotech (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2025 3:15 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form DEFA14A | |
04/02/2025 11:15 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form EFFECT | |
04/02/2025 11:15 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form EFFECT | |
04/02/2025 11:15 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form EFFECT | |
04/02/2025 11:15 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form EFFECT | |
04/01/2025 5:39 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form POS AM | |
04/01/2025 5:39 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form POS AM | |
04/01/2025 5:42 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form POS AM | |
Get the Latest News and Ratings for FBIOP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
04/01/2025 5:42 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form POS AM | |
03/10/2025 7:30 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/10/2025 7:30 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2025 3:25 PM | Checkpoint Therapeutics, Inc. (Issuer) Fortress Biotech, Inc. (Reporting) Fortress Biotech (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2025 3:20 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/06/2025 7:05 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2025 5:26 PM | Checkpoint Therapeutics, Inc. (Subject) Fortress Biotech, Inc. (Filed by) Fortress Biotech (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025 5:26 PM | Fortress Biotech, Inc. (Filed by) Fortress Biotech (Filed by) MUSTANG BIO, INC. (Subject)
| Form SCHEDULE 13D/A | |
01/03/2025 4:50 PM | AVENUE THERAPEUTICS, INC. (Subject) Fortress Biotech, Inc. (Filed by) Fortress Biotech (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025 3:20 PM | Fortress Biotech, Inc. (Reporting) Fortress Biotech (Reporting) MUSTANG BIO, INC. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/03/2025 3:21 PM | AVENUE THERAPEUTICS, INC. (Issuer) Fortress Biotech, Inc. (Reporting) Fortress Biotech (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/23/2024 3:30 PM | Fortress Biotech, Inc. (Issuer) Fortress Biotech (Issuer) Jin David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:50 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 3:24 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 8:11 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 3:05 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 424B3 | |
10/25/2024 9:15 AM | Fortress Biotech, Inc. (Subject) Fortress Biotech (Subject) HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/07/2024 11:15 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form EFFECT | |
09/27/2024 3:53 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
09/25/2024 3:45 PM | Fortress Biotech, Inc. (Issuer) Fortress Biotech (Issuer) ROSENWALD LINDSAY A MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 3:45 PM | Fortress Biotech, Inc. (Subject) Fortress Biotech (Subject) ROSENWALD LINDSAY A MD (Filed by)
| Form SC 13D/A | |
09/23/2024 7:00 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 424B5 | |
09/20/2024 8:28 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 424B5 | |
08/13/2024 3:15 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2024 4:04 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 424B5 | |
07/25/2024 4:26 PM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2024 7:00 AM | Fortress Biotech, Inc. (Filer) Fortress Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 7:42 AM | Fortress Biotech, Inc. (Issuer) Fortress Biotech (Issuer) Jin David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 7:00 AM | Fortress Biotech, Inc. (Issuer) Fortress Biotech (Issuer) ROSENWALD LINDSAY A MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 7:30 AM | Fortress Biotech, Inc. (Issuer) Fortress Biotech (Issuer) ROSENWALD LINDSAY A MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |